PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study identifies a likely key driver of colorectal cancer development and progression

2014-04-14
(Press-News.org) COLUMBUS, Ohio – A new study identifies a molecule that is a probable driving force in colorectal cancer and suggests that the molecule could be an important target for colorectal cancer treatment and a valuable biomarker of tumor progression. The study of microRNA-135b (miR-135b) in two animal models and human tumors was published in the journal Cancer Cell and was led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and at the University of Glasgow in the United Kingdom. The researchers demonstrate that miR-135b is present at abnormally high levels in both mouse and human colorectal (CRC) tumors. The overexpression can be induced by the mutations in either well-known oncogenes or tumor-suppressor genes that frequently occur in CRC, the researchers say. "We found that miR-135b is up-regulated in both sporadic and inflammatory bowel disease-associated colorectal cancer, and that its up-regulation is associated with tumor stage and poor clinical outcome," says principal investigator Carlo M. Croce, MD, chair of molecular virology, immunology and medical genetics, and director of Human Cancer Genetics at Ohio State and the OSUCCC – James. "Our findings provide proof-of-principle that anti-miR-135b has significant therapeutic potential in colorectal cancer treatment," says Croce, who is also the John W. Wolfe Chair in Human Cancer Genetics. For this study, Croce and his collaborators used a CRC mouse model based on loss of a tumor suppressor and a model based on inflammation and oncogene activation; human tumors from a cohort of sporadic CRC and inflammatory-bowel-disease associated CRC; human and animal cell lines and data from The Cancer Genome Atlas. Key findings included: MiR-135b up-regulation occurs in both sporadic and inflammatory bowel disease-associated CRC, and it is associated with tumor stage and poor clinical outcome; Loss of the APC gene, deregulation of the PTEN/PI3K pathway and over-expression of the SRC oncogene all trigger miR-135b over-expression; Artificial miR-135b over-expression increases cell proliferation and reduces apoptosis, as occurs with APC loss or PI3K or SRC activation. Delivering anti-miR-135b in an inflammation-related CRC mouse model affected proliferation and apoptosis, resulting in reduced tumor number and size. INFORMATION: Funding from the National Institutes of Health (grants U01 CA152758, RC2 CA148302, 1R01 CA078230, AI043477, DK035108, K99-DK088589), the Kimmel Cancer Foundation Translational Scholar Award and Glasgow University Start-Up funds, the AACR, the Crohn's and Colitis Foundation of America supported this research. Other researchers involved in this study were Pierluigi Gasparini, Francesca Lovat, Alessio Paone, Luciano Cascione, Khlea M. Sumani, Stefania Carasi, Hansjuerg Alder, Gerard J Nuovo, Wendy Frankel, Joanna Groden, The Ohio State University; Muller Fabbri, Children's Hospital Los Angeles; Nicola Valeri, Chiara Braconi, Andrea Lampis, Viola Paulus-Hock, University of Glasgow, Glasgow, United Kingdom (UK); Claudio Murgia, Rachel A Ridgway, Julia Cordero, Owen J Sansom, Beatson Institute for Cancer Research, Glasgow, UK; Jonathan R. Hart, Lynn Ueno, The Scripps Research Institute; Sergei I. Grivennikov, Peter K Vogt, Michael Karin, University of California San Diego; Angelo Veronese, Aging Research Center G. d'Annunzio University Foundation, Chieti, Italy; Mary P Moyer, INCELL Corporation; and Massimo Rugge, Matteo Fassan, University of Padova, Italy. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only four centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State's cancer program as "exceptional," the highest rating given by NCI survey teams. As the cancer program's 228-bed adult patient-care component, The James is a "Top Hospital" as named by the Leapfrog Group and one of the top cancer hospitals in the nation as ranked by U.S.News & World Report.


ELSE PRESS RELEASES FROM THIS DATE:

Dietary supplement use among US adults more prevalent than previously thought

2014-04-14
Washington, D.C., April 14, 2014—Dietary supplement use by U.S. adults is more prevalent than indicated by published data from the National Health and Nutrition Examination Surveys (NHANES), according to a new article in the peer-reviewed Journal of the American College of Nutrition (JACN). The review article is based on five consecutive years of online market research studies, conducted by Ipsos Public Affairs for the Council for Responsible Nutrition (CRN). According to Annette Dickinson, Ph.D., corresponding author and a consultant for CRN, "This new review adds to ...

Young dads at high risk of depression, too

2014-04-14
CHICAGO --- Depression can hit young fathers hard -- with symptoms increasing dramatically during some of the most important years of their children's lives, a new Northwestern Medicine® study has found. Depressive symptoms increased on average by 68 percent over the first five years of fatherhood for these young men, who were around 25 years old when they became fathers and whom lived in the same home as their children. The results of the study were published April 14 in the journal Pediatrics. This study is the first to identify when young fathers are at increased ...

Osteoporosis drugs appear to impede cell membrane repair

Osteoporosis drugs appear to impede cell membrane repair
2014-04-14
AUGUSTA, Ga. –A class of drugs widely used to treat osteoporosis appears to impede a cell's ability to repair a protective outer membrane that helps determine what enters and exits, researchers report. The inability to quickly repair a membrane is lethal to a cell and may help explain the rare and serious side effect of jawbone destruction that can occur following dental work in patients taking these drugs, said Caroline Lewis, a sophomore at the Medical College of Georgia at Georgia Regents University. "The bottom line is it inhibits cell membrane repair in two distinct ...

Long-term antibiotic treatment for Q fever causes weight gain

2014-04-14
Scientists have unearthed still more evidence that antibiotics can contribute to obesity. Research published ahead of print in the journal Antimicrobial Agents and Chemotherapy suggests that patients on long-term antibiotic treatment gained weight and had significant changes in their gut microbiota. The study, led by Didier Raoult, of Aix-Marseille University, Marseille, France, followed 48 patients who were being treated long-term with doxycycline and hydroxychloroquine for Q fever, and 34 control subjects. Nearly one quarter of the treated patients gained anywhere ...

Shiny quantum dots brighten future of solar cells

Shiny quantum dots brighten future of solar cells
2014-04-14
A house window that doubles as a solar panel could be on the horizon, thanks to recent quantum-dot work by Los Alamos National Laboratory researchers in collaboration with scientists from University of Milano-Bicocca (UNIMIB), Italy. Their project demonstrates that superior light-emitting properties of quantum dots can be applied in solar energy by helping more efficiently harvest sunlight. "The key accomplishment is the demonstration of large-area luminescent solar concentrators that use a new generation of specially engineered quantum dots," said lead researcher Victor ...

UT Dallas study: Youth who fail to envision future commit more crimes

UT Dallas study: Youth who fail to envision future commit more crimes
2014-04-14
In a UT Dallas study involving serious youth offenders, the answer to one open-ended question predicted the teenagers' offending patterns for the next seven years: "How long do you think you'll live?" According to the study, having little hope for the future encourages offending over time. Author Dr. Alex Piquero said the study found those who don't view a very long life ahead of them offend at very high rates and commit more serious offenses, while those who believe they're going to die much later in life offend much less. "In a lot of distressed communities and for ...

Device turns flat surface into spherical antenna

Device turns flat surface into spherical antenna
2014-04-14
WASHINGTON D.C., April 14, 2014 -- By depositing an array of tiny, metallic, U-shaped structures onto a dielectric material, a team of researchers in China has created a new artificial surface that can bend and focus electromagnetic waves the same way an antenna does. This breakthrough, which the team is calling the first broadband transformation optics metasurface lens, may lead to the creation of new types of antennas that are flat, ultra low-profile or conformal to the shape of curved surfaces. The new lens, described in AIP Publishing's journal Applied Physics Letters, ...

The science of caffeine, the world's most popular drug (video)

The science of caffeine, the worlds most popular drug (video)
2014-04-14
WASHINGTON, April 14, 2014 — It seems there are new caffeine-infused products hitting the shelves every day. From energy drinks to gum and even jerky, our love affair with that little molecule shows no signs of slowing. In the American Chemical Society's (ACS') latest Reactions video, we look at the science behind the world's most popular drug, including why it keeps you awake and how much caffeine is too much. The video is available at http://youtu.be/YuJOhpNS0IY. INFORMATION: Subscribe to the series at Reactions YouTube, and follow us on Twitter @ACSreactions to be ...

Study gives high marks to NC Pre-K program

Study gives high marks to NC Pre-K program
2014-04-14
Scientists from UNC's Frank Porter Graham Child Development Institute have released their new study of NC Pre-K, the state's program to prepare four-year-olds for success in kindergarten. According to FPG's report, students enrolled in NC Pre-K show significant gains across all areas of learning. "Children are progressing at an even greater rate during their participation in NC Pre-K than expected for normal developmental growth," said senior scientist Ellen Peisner-Feinberg, who leads the FPG team that has studied the program and provided it with recommendations for ...

Low birth weight, less breastfeeding create later health risks

2014-04-14
Lower weight babies and babies who aren't breastfed or not breastfed for long are at greater risk of developing chronic inflammation and related health problems later in life, according to a new study. "There were good reasons to hypothesize that breastfeeding was important to influencing levels of inflammation in adulthood," says Thomas McDade (Northwestern University), a CIFAR (Canadian Institute for Advanced Research) Fellow in the Child & Brain Development program. "It changes the microbiome. It promotes development of the immune system. Children who are breastfed ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Study identifies a likely key driver of colorectal cancer development and progression